Selective mediastinal node irradiation based on FDG-PET scan data in patients with non–small-cell lung cancer: A prospective clinical study
- 1 July 2005
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 62 (4), 988-994
- https://doi.org/10.1016/j.ijrobp.2004.12.019
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non–small-cell lung cancer: A modeling studyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer locationLung Cancer, 2004
- Current Concepts in the Mediastinal Lymph Node Staging of Nonsmall Cell Lung CancerAnnals of Surgery, 2003
- Staging of Non–Small-Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed TomographyNew England Journal of Medicine, 2003
- The location of recurrences in patients with non-small cell lungcancer treated with involved-field irradiationLung Cancer, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trialRadiotherapy and Oncology, 1999
- Staging non—small cell lung cancer by whole-body positron emission tomographic imagingThe Annals of Thoracic Surgery, 1995
- Endpoints for multimodal clinical trials in Stage III non-small cell lung cancer (NSCLC): a consensus reportLung Cancer, 1994
- The late effects of toxicity scoringInternational Journal of Radiation Oncology*Biology*Physics, 1988